WEGO HOLDING COMPANY LIMITED ("WEGO") established in March 1988, and the major business of WEGO focus on medical devices and pharmaceuticals. In addition, WEGO develops some other business such as real estate, investment and so on. WEGO has 9 industry groups and more than 30 subsidiaries. The main products of WEGO are infusion set& syringe, blood transfusion equipment, heart stent & intracardiac consumable,IV catheter & special needle, blood purification equipment and consumables, orthopedic material, operation room equipment and accessories, wound care product, minimally invasive instrument and equipment, ICU product and accessories, high-capacity injection and pharmaceutical, renal product, biological diagnostic reagent, PVC & non-PVC material and so on. WEGO produces more than 30 series, 400 categories and 40,000 specifications products, and has become one of the most reliable suppliers of medical system in the word. At the same time, WEGO energetically takes part in healthcare service and provides renal dialysis service. WEGO's holding subsidiary ---SHANDONG WEIGAO GROUP MEDICAL POLYMER CO., LIMITED is listed in Hong Kong.
CE and FDA approved Absorbable sutures by full US and UK material. WEGOSUTURES conformity with the USP and EP standard. WEGOSUTURE is soft and easy for safe knot.
Sterile by EO conformity with ISO11137 by a CE marked sterilize center.
WEGO-Polyester Features
Structure
Polyfilament, braided and coated
Chemical Composition
Polyethylene terephthalate
Coating
Silicone or Uncoated
Color
Green or White
Sizes
USP 3- USP 6/0 metric6 - metric 0.7
Mass absorption
Non-absorbable
Indications
Skin Closure, Cardiovascular surgery, Vascular surgery, Ophthalmology, Orthopaedics, Gastrointestinal surgery, Neurosurgery
Contraindications
Not Known
Sterilization
Ethylene oxide
Audited Supplier 
){kind=link}